Medicine and Dentistry
Thyroid Cancer
100%
Thyroidectomy
73%
Quality of Life
62%
Neoplasm
57%
Diseases
55%
Health Care Cost
52%
Neck
47%
Cost-Effectiveness Analysis
47%
Surgeon
45%
Parathyroidectomy
44%
Neck Dissection
44%
Primary Hyperparathyroidism
42%
Adrenalectomy
41%
Papillary Thyroid Cancer
40%
Multiple Endocrine Neoplasia Type I
35%
Patient-Reported Outcome
31%
Radioactive Iodine
30%
Cancer
30%
Differentiated Thyroid Cancer
29%
Adrenal Cortex Carcinoma
29%
Primary Hyperaldosteronism
29%
Thyroid Carcinoma
24%
Outcome Assessment
23%
Lymph Node
22%
Malignant Neoplasm
21%
Pheochromocytoma
19%
Recurrent Disease
19%
Thyroid Nodule
18%
Prognostic Factor
17%
Parathyroid
17%
Fine-Needle Aspiration
16%
Adrenal Tumor
15%
Metastatic Carcinoma
15%
Anaplastic Thyroid Carcinoma
14%
Base
12%
Surgical Approach
11%
Myofilament
11%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
11%
Hyperparathyroidism
11%
Nesidioblastosis
10%
Overall Survival
10%
Oncology
10%
Isotopes of Calcium
9%
Computer Assisted Tomography
9%
Parathyroid Hormone
9%
Thyroid Tumor
9%
Incidentaloma
9%
Lymph Node Metastasis
9%
Clinician
9%
Odds Ratio
8%
Keyphrases
Thyroid Cancer
71%
Parathyroidectomy
59%
Papillary Thyroid Cancer
49%
Cost-effectiveness Analysis
48%
Primary Hyperparathyroidism (pHPT)
47%
United States
43%
Thyroid Cancer Survivors
42%
Health-related Quality of Life
40%
Multiple Endocrine Neoplasia Type 1 (MEN1)
38%
Total Thyroidectomy
36%
Adrenocortical Carcinoma
35%
Quality of Life
34%
Patient-Reported Outcomes Measurement Information System (PROMIS)
33%
Cost-effectiveness
30%
Lymph Node
29%
Endocrine Surgeons
27%
Adrenalectomy
26%
Tumor
25%
Quality-adjusted Life Years
24%
Sporadic Primary Hyperparathyroidism
24%
Thyroid Carcinoma
24%
Pheochromocytoma
22%
Mesenchymal Stem Cells
21%
Financial Burden
21%
Modified Radical Neck Dissection
21%
Malignancy
19%
Laparoscopic Adrenalectomy
19%
Differentiated Thyroid Cancer
19%
Prognostic Factors
18%
Thyroid Nodule
18%
Radioiodine Ablation
17%
NCCN Guidelines
17%
Tumor Size
17%
Primary Aldosteronism
16%
Medullary Thyroid Cancer
16%
Surgeons
16%
IoPTH
16%
Extent of Surgery
16%
Consecutive Patients
16%
Risk Assessment
15%
Glands
15%
Surgical Management
15%
Multigland Disease
15%
Surgical Outcomes
15%
Neck Dissection
15%
Nonhuman Primate
15%
Treatment Strategy
15%
Anaplastic Thyroid Cancer
14%
Hyperaldosteronism
14%
Familial Non-medullary Thyroid Cancer
14%